AGM Results

Electrical Geodesics, Inc.

AGM Results

EUGENE, OREGON, US, 3 July 2015 - Electrical Geodesics, Inc. ("EGI" or the "Company"), a leading neurodiagnostic medical technology company, today announces that the resolutions set out in the Company's Notice of Annual General Meeting (the "Meeting") issued to stockholders on 5 June 2015 were passed by stockholders at the Meeting held in Eugene at 9.30 PST yesterday. The Annual Report and Accounts for the year ended 31 December 2014 were also received by the meeting.

Voting Results

Proxy and actual voting results in respect of the Ordinary Resolutions put to the meeting are shown below.

Ordinary Resolutions

1.a To reappoint Don Tucker as a director

1.b To reappoint Ann Bunnenberg as a director

1.c To reappoint Christine Soden as a director

1.d To reappoint John Brown as a director

1.e To reappoint Raymond Englander as a director

Copies of all resolutions and all documents referred to above are available on the Company's website at www.egi.com.

For more information contact:

Notes to Editors

Electrical Geodesics, Inc. in Summary

Founded in 1992, EGI designs, develops and commercialises a range of non-invasive neurodiagnostic and neuromodulation products used to monitor, interpret and modulate brain activity, based on its proprietary dense array electroencephalography ("dEEG") platform technology. The Company's technology uses up to 256 sensors, providing much higher resolution brain activity data compared to conventional 8 or 16 channel EEG and is used in medical, clinical and research settings in a diverse range of applications including important areas such as the diagnosis and monitoring of epilepsy, neurosurgical planning, sleep assessment, and many others.

EGI's dEEG systems, available in the GES 300 and now the GES 400 lines, capitalise on the Company's unique Geodesic Sensor Net which allows faster, easier, and more convenient placement of many EEG sensors in an even distribution over the entire scalp, providing more accurate and precise diagnosis and measurement. EGI's technology is now widely used in neuroscience research laboratories and is becoming more commonly used in clinics, care centers, and hospitals around the world. Data is measured and visualised using EGI's proprietary amplifier technology and software, providing a complete, advanced, high-resolution EEG platform. The Company's products are compatible with multiple diagnostic and imaging technologies, including magnetic resonance (MR) imaging, functional MRI (fMRI), and magneto-encephalography (MEG).

See our website www.egi.com

Glossary

In April 2013 EGI commenced trading on the London Stock Exchange AIM market under the symbol EGI.L. See www.egi.com for more information on the Company.